CLINICAL_TRIALS
trial_result
· 2017-03-28
Clinical Trial Update: Dextro-Amphetamine Versus Caffeine in Treatment-resistant OCD [NA]
Summary
A clinical trial comparing dextro-amphetamine and caffeine for treatment-resistant obsessive-compulsive disorder has completed, with results posted in March 201…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Stanford University | Conditions: Obsessive-Compulsive Disorder | NA | Status: COMPLETED | Results posted: 2017-03-28